Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             159 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Absence of antiviral activity of the broad-spectrum picornavirus inhibitor disoxaril (WIN 51711) against hepatitis A virus 1988
9 1-2 p. 98-
1 p.
artikel
2 A comparison of adjuvant efficacy for a recombinant herpes simplex virus glycoprotein vaccine 1988
9 1-2 p. 126-
1 p.
artikel
3 Activation of RNase L by phosphorothioate analogs of 2-5A trimer and tetramer cores 1988
9 1-2 p. 94-
1 p.
artikel
4 Activity of 5-bromovinyl-2′-deoxycytidine in combination with deaminase inhibitors against herpes simplex virus type 1 1988
9 1-2 p. 83-
1 p.
artikel
5 Adverse effects of recombinant human tumor necrosis factor on the course of Simian varicella virus infection in monkeys 1988
9 1-2 p. 135-
1 p.
artikel
6 AIDS Encephalopathy: An AZT derivative which may become “Locked” in the central nervous system 1988
9 1-2 p. 118-
1 p.
artikel
7 Alpha blockade inhibits induced ocular shedding of latent HSV-1 1988
9 1-2 p. 145-
1 p.
artikel
8 Annual meeting of the international society for interferon research 1988
9 1-2 p. II-
1 p.
artikel
9 Anti-influenza virus activity of rimantadine: Sensitivity of recent epidemic strains tested by three methods and comparison with amantadine and the new antiviral compound ICI 130,685 1988
9 1-2 p. 152-
1 p.
artikel
10 Anti-RNA-viral activities of phenanthridones related to narciclasine ( I , R=H, R′=OH) 1988
9 1-2 p. 97-
1 p.
artikel
11 Antiviral activities of immuno-modulating agent ACPS in cell cultures and in mice 1988
9 1-2 p. 130-
1 p.
artikel
12 Antiviral activity of acyclic tubercidin analogs 1988
9 1-2 p. 81-
1 p.
artikel
13 Antiviral activity of compound 102 against guinea pig cytomegalovirus infection 1988
9 1-2 p. 140-
1 p.
artikel
14 Antiviral activity of HOE 602 and analogues against herpes simplex virus infections 1988
9 1-2 p. 153-
1 p.
artikel
15 Antiviral activity of natural 3-methoxyflavones 1988
9 1-2 p. 101-
1 p.
artikel
16 Antiviral activity of synthetic 3-methoxyflavones 1988
9 1-2 p. 102-
1 p.
artikel
17 Antiviral and antibacterial effect of pyridopeptonal 1988
9 1-2 p. 106-
1 p.
artikel
18 Antiviral and immunomodulating activities of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-60 Ikeda, Satoru
1988
9 1-2 p. 37-46
10 p.
artikel
19 Antiviral effect of compound 2′-nor-cGMP against cytomegalovirus infection in the guinea pig model 1988
9 1-2 p. 141-
1 p.
artikel
20 Antiviral efficacy of newer antiviral agents in animals 1988
9 1-2 p. 144-
1 p.
artikel
21 Antiviral-immunomodulator R-837 induces 2,5-oligoadenylate synthetase (2,5 AS) Activity in mononuclear cells of treated guinea pigs 1988
9 1-2 p. 130-
1 p.
artikel
22 Anti-viral therapy in woodchucks during the late acute phase of woodchuck hepatitis virus (WHV) infection 1988
9 1-2 p. 85-
1 p.
artikel
23 A rapid screening method for anti-HIV compounds 1988
9 1-2 p. 117-
1 p.
artikel
24 A study effects of ribavirin on the white blood cell system and platelet in patients with epidemic hemorrhagic fever 1988
9 1-2 p. 148-
1 p.
artikel
25 3′azidothymidine (AZT) prevents the dissemination of retrovirus in LP-BM5 MuLV-infected C57BL/6 mice 1988
9 1-2 p. 86-
1 p.
artikel
26 Beijing duck hepatitis used as an animal model for screening and evaluating antihepatitis B virus drugs 1988
9 1-2 p. 89-
1 p.
artikel
27 Biological properties of amantadine-resistant influenza virus mutants 1988
9 1-2 p. 128-
1 p.
artikel
28 Brain-enhanced delivery of antiviral agents 1988
9 1-2 p. 127-
1 p.
artikel
29 Cell-mediated antiherpetic activity of a streptococcal preparation (OK-432) in immunocompromized hosts 1988
9 1-2 p. 136-
1 p.
artikel
30 Chemical synthesis of phosphorothioate analogs of 2-5A trimer and tetramer 1988
9 1-2 p. 94-
1 p.
artikel
31 Clinical experience with parenteral foscarnet 1988
9 1-2 p. 147-
1 p.
artikel
32 Cloning and expression of the herpes simplex virus type 1 DNA polymerase in bacteria 1988
9 1-2 p. 92-
1 p.
artikel
33 Combination of acyclovir (ACV) plus vidarabine (ara-A) or ACV plus interferon (IFN) against herpes simplex virus type 1 (HSV-1) and HSV-2 in cell cultures 1988
9 1-2 p. 138-
1 p.
artikel
34 Combined antiviral action of tumor necrosis factor and interferon in vivo 1988
9 1-2 p. 159-
1 p.
artikel
35 Combined effects of r interferon-β and AZT on HIV replication In vitro 1988
9 1-2 p. 138-
1 p.
artikel
36 Comparative antiviral activities of BV-araU and acyclovir In Vitro and In Vivo 1988
9 1-2 p. 87-
1 p.
artikel
37 Comparative susceptibility of reactivated herpes simplex virusus (HSV) to three antiviral agents 1988
9 1-2 p. 129-
1 p.
artikel
38 Comparison of antiviral efficacy and mechanism of action of immunomodulators against exotic RNA viruses 1988
9 1-2 p. 134-
1 p.
artikel
39 Comparison of the toxicity and anti-respiratory syncytial virus activity of papaverine and pyrazofurin 1988
9 1-2 p. 105-
1 p.
artikel
40 Comparison of treatment with adenine arabinoside, 2′, 3′-diacetate (ara-ADA) with adenine arabinoside (ara-A) and acyclovir (ACV) in herpes simplex virus (HSV) type 1 infections in mice 1988
9 1-2 p. 139-
1 p.
artikel
41 Computer assisted molecular design of antisense oligonucleotide-intercalator conjugates as antiviral agents 1988
9 1-2 p. 93-
1 p.
artikel
42 Conformation and antiherpes activity of 3′- and 5′-azido and amino analogs of 5-methoxy-methyl-2′-deoxyuridine 1988
9 1-2 p. 112-
1 p.
artikel
43 Corporate sponsors 1988
9 1-2 p. 62-
1 p.
artikel
44 Correlation of antiretroviral agents activity against HIV-1 and SIV: Implications for studies in non-human primate models 1988
9 1-2 p. 133-
1 p.
artikel
45 Cytomegalovirus antigens identified by human monoclonal antibodies 1988
9 1-2 p. 158-
1 p.
artikel
46 Cytomegalovirus (CMV) infection in immunocompromised guinea pigs: A model for testing antiviral agents In vivo 1988
9 1-2 p. 141-
1 p.
artikel
47 Determination of antiviral activity of ganciclovir (DHPG) and antiretroviral agents against human cytomegalovirus (HCMV) using a novel DNA-DNA hybridization assay 1988
9 1-2 p. 114-
1 p.
artikel
48 2′,3′-dideoxy-2′,3′-didehydrothymidine (D4T): A potent and selective agent against human immunodeficiency virus (HIV) 1988
9 1-2 p. 119-
1 p.
artikel
49 Differential reconstitution of azidothymidine-induced inhibition of mitogenic responses by interleukin-2 in lymphocytes from patients with the acquired immunodeficiency syndrome 1988
9 1-2 p. 158-
1 p.
artikel
50 Differential response of T-lymphoblastoid cell lines to infection with HIV and to antiviral drugs: Implications for large-scale anti-HIV drug screening 1988
9 1-2 p. 117-
1 p.
artikel
51 Editorial Board 1988
9 1-2 p. ii-iii
nvt p.
artikel
52 Effective therapy of epidemic hemorrhagic fever patients with ribarivin decreasing G mortality & reversible anemia 1988
9 1-2 p. 147-
1 p.
artikel
53 Effect of 2-acetylpyridine thiosemicarbazone on host range mutants of herpes simplex virus type 1 lacking ribonucleotide reductase activity 1988
9 1-2 p. 156-
1 p.
artikel
54 Effect of 2-acetylpyridine thiosemicarbazones on In vivo type 2 herpesvirus infections 1988
9 1-2 p. 140-
1 p.
artikel
55 Effect of combination therapy with adenine arabinoside (ara-A) and acyclovir (ACV) in a murine model of herpes simplex virus type 1 (HSV-1) encephalitis 1988
9 1-2 p. 139-
1 p.
artikel
56 Effect of 1-(2′-deoxy-2′-fluoro-β-D-arabinofuranosyl)-5-ethyluridine (FEAU) on herpes keratitis in rabbits 1988
9 1-2 p. 144-
1 p.
artikel
57 Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG) on cell mediated immune (CMI) response of normal and murine cytomegalovirus (MCMV) infected mice 1988
9 1-2 p. 137-
1 p.
artikel
58 Effect of liposome encapsulated recombinant herpes simplex glycoprotein in controlling recurrent herpes genitalis 1988
9 1-2 p. 153-
1 p.
artikel
59 Effect of LY253963 on ferret body temperature following influenza virus infection 1988
9 1-2 p. 145-
1 p.
artikel
60 Effect of polyene macrolide antibiotics and their derivatives on human immunodeficiency virus (HIV) 1988
9 1-2 p. 104-
1 p.
artikel
61 Effect of ribavirin on hepatitis A virus replication in vitro 1988
9 1-2 p. 82-
1 p.
artikel
62 Effect of small dosage of interferon on viral markers of chronic hepatitis B 1988
9 1-2 p. 151-
1 p.
artikel
63 Effect of small dose interferon of human leukocytes on three viral antigen of hepatitis B 1988
9 1-2 p. 151-
1 p.
artikel
64 Effects and mode of action of ribavirin analog N3844 against semliki forest virus 1988
9 1-2 p. 97-
1 p.
artikel
65 Effects of a series of immunomodulators on experimental phlebovirus infections 1988
9 1-2 p. 125-
1 p.
artikel
66 Efficacy of a novel orally active immunomodulator, S-26308 against arbovirus infections 1988
9 1-2 p. 88-
1 p.
artikel
67 Elucidation of the mechanism responsible for the synergistic effects of dl-Homocysteine (Hcy) on the Anti-vaccinia virus effects of the S -adenosylhomocysteine (AdoHcy) Hydrolase inhibitor 9-( trans -2′, trans-3′-dihydroxycyclopent-4′-enyl)-adenine (1) 1988
9 1-2 p. 96-
1 p.
artikel
68 Enhanced efficacy of nucleoside analogs and recombinant alpha interferon in weanling mice lethally infected with herpes simplex virus type 2 Crane, Lawrence R.
1988
9 1-2 p. 1-9
9 p.
artikel
69 Enhancement of alphavirus replication in cultured cells by external alkaline pH 1988
9 1-2 p. 98-
1 p.
artikel
70 Establishment of screening system for antiviral substances - on Hantaan virus as target - 1988
9 1-2 p. 116-
1 p.
artikel
71 Evaluation of anti-varicella-zoster virus activity of acyclovir by a nucleic acid hybridization assay 1988
9 1-2 p. 115-
1 p.
artikel
72 Experimental infection of pigtailed macaques with the simian T-cell leukemia virus (STLV-I): Model for the etiopathogenesis of human T-cell leukemia virus (HTLV-I) infection and associated disease 1988
9 1-2 p. 131-
1 p.
artikel
73 3′-flouro- and 3′-azido-substituted pyrimidine 2′,3′-dideoxynucleoside derivatives and potent anti-retrovirus agents 1988
9 1-2 p. 120-
1 p.
artikel
74 Focal herpes simplex virus type 1 (HSV-1) encephalitis (HSE) of the olfactory system: A primary infection rabbit model of human disease 1988
9 1-2 p. 143-
1 p.
artikel
75 Herpes simplex virus type 2 genital infection in male guinea pigs 1988
9 1-2 p. 142-
1 p.
artikel
76 HPMPG: An acyclic guanosine phosphonate which exhibits broad spectrum, antiviral activity 1988
9 1-2 p. 107-
1 p.
artikel
77 Improvement of some hematological parameters in the ribavirin treated epidemic hemorrhagic fever patments in Hubei, China 1988
9 1-2 p. 148-
1 p.
artikel
78 Inactivation of enveloped viruses in human serum and infant formula by human milk lipids 1988
9 1-2 p. 113-
1 p.
artikel
79 Influence of adjuvant on glycoprotein immunotherapy of recurrent genital herpes 1988
9 1-2 p. 142-
1 p.
artikel
80 Influence of ascorbate on the antiviral activity of quercetin derivatives 1988
9 1-2 p. 101-
1 p.
artikel
81 Inhibition mechanisms of antiretroviral compounds 1988
9 1-2 p. 104-
1 p.
artikel
82 Inhibition of calf thymus DNA topoisomerase 1 -mediated relaxation of supercolled DNA by 2′,5′-oligoadenylates 1988
9 1-2 p. 92-
1 p.
artikel
83 Inhibition of Epstein-Barr virus transformation of B-cells by 3′-Azido-3′-deoxythymidine and interferon alpha and gamma 1988
9 1-2 p. 108-
1 p.
artikel
84 Inhibition of herpes simplex virus type 2 replication in vitro by 1-N-pentadecanoyl-3″-N-trifluoroacetyl kanamycin A Rahman, M.M.
1988
9 1-2 p. 11-22
12 p.
artikel
85 Inhibition of HIV-1 and simian immunodeficiency virus (SIV) reverse transcriptases by the 5′-triphosphates of 3′-azido-2′,3′-dideoxyuridine (CS-87), 3′-azido-3′-deoxythymidine (AZT), and 3′-azido-2′,3′-dideoxy-5-ethyluridine (CS-85) 1988
9 1-2 p. 84-
1 p.
artikel
86 Inhibition of HSV-2 replication in vero cell by spleen and lymphnode cells of mice infected with HSV-2 and treated with interferons 1988
9 1-2 p. 137-
1 p.
artikel
87 Inhibition of human hepatitis B virus DNA polymerase (HBV DNAP) and duck hepatitis B virus DNA polymerase (DHBV DNAP) by triphosphates of thymidine analogs 1988
9 1-2 p. 99-
1 p.
artikel
88 Inhibition of human immunodeficiency virus (HIV) infection of fresh peripheral blood monocyte/macrophages (M/M) by dideoxynucleosides and phosphonoformate 1988
9 1-2 p. 157-
1 p.
artikel
89 Inhibition of human immunodeficiency virus replication by derivatives of stearic acid 1988
9 1-2 p. 105-
1 p.
artikel
90 Inhibition of in vivo herpes simplex virus reactivation by acyclovir 1988
9 1-2 p. 87-
1 p.
artikel
91 Inhibition of phosphorylation and viral protein kinase activity by D609 (tricyclodecan-9-yl-xanthogenate) 1988
9 1-2 p. 95-
1 p.
artikel
92 Inhibitors of glycoprotein-trimming enzymes block HIV and CMV growth 1988
9 1-2 p. 152-
1 p.
artikel
93 Inhibitors of herpes simplex virus thymidine kinase synthesis and biological properties 1988
9 1-2 p. 84-
1 p.
artikel
94 Interferon alfa-n1 in the treatment of refractory genital warts: results of multistudy program 1988
9 1-2 p. 123-
1 p.
artikel
95 Interferon alters transport of vesicular stomatitis virus glycoprotein 1988
9 1-2 p. 132-
1 p.
artikel
96 International society for antiviral research 1988
9 1-2 p. I-
1 p.
artikel
97 International symposium: Basic and clinical approaches to virus chemotherapy 1988
9 1-2 p. I-
1 p.
artikel
98 Intranasal tolerance of recombinant interferon-αcon1 in healthy volunteers 1988
9 1-2 p. 122-
1 p.
artikel
99 Intravenous ribavirin therapy of hemorrhagic fever with renal syndrome (HFRS) 1988
9 1-2 p. 123-
1 p.
artikel
100 Introduction to sponsors 1988
9 1-2 p. 60-61
2 p.
artikel
101 In vitro and in vivo antiherpes activity of 4-0-difluoromethyl-5-substituted uracil nucleoside analogs 1988
9 1-2 p. 112-
1 p.
artikel
102 In vitro and in vivo Development of drug resistance by rhinoviruses 1988
9 1-2 p. 128-
1 p.
artikel
103 In vitro and in vivo evaluations of compounds against representative viruses from seven virus families 1988
9 1-2 p. 116-
1 p.
artikel
104 In vitro antiviral activity studies of poly r(A–U) and intercalating agents 1988
9 1-2 p. 93-
1 p.
artikel
105 In vitro antiviral spectrum of LY253963 1988
9 1-2 p. 100-
1 p.
artikel
106 In vivo reconstruction studies: effects of pathogenic ACV-resistant virus on pattern of infection and clinical outcome 1988
9 1-2 p. 124-
1 p.
artikel
107 Isolation and characterization of an arildone-resistant poliovirus 2 mutant with an altered capsid protein VP1 Eggers, Hans J.
1988
9 1-2 p. 23-35
13 p.
artikel
108 Late intervention therapy using immunomodulators and antiserum in a of model Flavivirus infection 1988
9 1-2 p. 134-
1 p.
artikel
109 Low dose interferon alfa-2b (IFN) delays the onset of symptoms in experimental rhinovirus (RV) colds 1988
9 1-2 p. 149-
1 p.
artikel
110 Mechanisms of the augmented resistance of trehalose-6,6′-dimycolate (TDM) treated mice to influenza virus infection 1988
9 1-2 p. 88-
1 p.
artikel
111 Metabolism of BV-araU in HSV-infected cells 1988
9 1-2 p. 110-
1 p.
artikel
112 3-methylquercetin prevents synthesis of negatively stranded viral RNA in poliovirus infected cells 1988
9 1-2 p. 103-
1 p.
artikel
113 Mismatched dsRNA (Ampligen) induces protection against genomic variants of the human immunodeffciency virus type 1 (HIV-1) in a multiplicity of target cells Montefiori, David C.
1988
9 1-2 p. 47-55
9 p.
artikel
114 Modulation of interferon/acyclovir effects by indomethacin in chronic hepatitis B 1988
9 1-2 p. 149-
1 p.
artikel
115 Murine retrovirus models in AIDS drug development 1988
9 1-2 p. 133-
1 p.
artikel
116 New inhibitors of polyamine (PA) Biosynthesis and their effect on the replication of human cytomegalovirus (HCMV) 1988
9 1-2 p. 110-
1 p.
artikel
117 On the antiviral activity of a polyphenolic complex, isolated from geranium sanguineum L 1988
9 1-2 p. 113-
1 p.
artikel
118 Pharmacological significance of selective uptake of nucleoside analogs by virus-infectal cells 1988
9 1-2 p. 157-
1 p.
artikel
119 Potent and selective antiviral activity of a new nucleoside analog (NSC-614846) against human immunodeficiency virus (HIV) in vitro 1988
9 1-2 p. 120-
1 p.
artikel
120 Program and abstracts from the second international conference on antiviral research 1988
9 1-2 p. 57-
1 p.
artikel
121 Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys 1988
9 1-2 p. 131-
1 p.
artikel
122 Prophylactic therapy with oral acyclovir (ACV) for experimental ultraviolet (UV) light-induced herpes simplex labialis 1988
9 1-2 p. 121-
1 p.
artikel
123 Proteolytic processing of virus proteins as a target for antiviral chemotherapy 1988
9 1-2 p. 106-
1 p.
artikel
124 Purification of a human protein related to the anti-influenza protein mx of mice 1988
9 1-2 p. 91-
1 p.
artikel
125 Reactogenicity and immunogenicity of a third yeast-derived hepatitis B vaccine (Cilag CC 2572-P-101) 1988
9 1-2 p. 143-
1 p.
artikel
126 Recombinant alpha and beta interferous inhibit epidemic isolates of acute hemorrhagic conjunctivities virus 1988
9 1-2 p. 132-
1 p.
artikel
127 Ribavirin but not interferon protects against Pichinde' arenavirus infection 1988
9 1-2 p. 135-
1 p.
artikel
128 Scientific program 1988
9 1-2 p. 63-80
18 p.
artikel
129 Selection of an oral prodrug (BRL 42810) for the anti-herpesvirus agent BRL 39123 1988
9 1-2 p. 146-
1 p.
artikel
130 Selective inhibition of HIV-1 envelope glycoprotein-induced syncytium formation 1988
9 1-2 p. 102-
1 p.
artikel
131 Selective inhibition of human cytomegalovirus replication by oxetanocin G 1988
9 1-2 p. 109-
1 p.
artikel
132 Sensitivity of 82 herpes simplex virus isolates to acyclovir and interferon α 1988
9 1-2 p. 129-
1 p.
artikel
133 (S)-9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine (S-HPMPA): Antiviral activity and pharmacokinetics 1988
9 1-2 p. 82-
1 p.
artikel
134 Simplified dosage zidovudine treatment of asymptomatic HIV-infected subjects 1988
9 1-2 p. 122-
1 p.
artikel
135 Some biological properties of BRL 42810, a well absorbed oral prodrug of the antiherpesvirus agent BRL 39123 1988
9 1-2 p. 146-
1 p.
artikel
136 Specificity of viral proteases: target for therapyy of infectious diseases 1988
9 1-2 p. 90-
1 p.
artikel
137 Studies on the mechanism of antiviral action of 5-(2-chlorethyl)-2′-deoxyuridine against herpes simplex virus 1988
9 1-2 p. 111-
1 p.
artikel
138 Studies on the mode of action of the new antiviral agent hydroxyphosphonylmethoxypropyl adenine (HPMPA) using bovine herpesvirus-1 1988
9 1-2 p. 107-
1 p.
artikel
139 Studies on two new antiviral agents against guinea pig lymphotropic herpesvirus infection, in vitro 1988
9 1-2 p. 83-
1 p.
artikel
140 Sugar modified oligonucleotides for the design of potential antiviral agents 1988
9 1-2 p. 155-
1 p.
artikel
141 Susceptibility of human immunodeficiency virus replication to acyclic adenosine analogues, and synergy in combination with azidothymidine 1988
9 1-2 p. 103-
1 p.
artikel
142 Synergisitic activity of 3′-azido-3′-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 in vitro 1988
9 1-2 p. 119-
1 p.
artikel
143 Synthesis and antiviral activity of 2′-deoxy-2′,2′-difluoro-d-ribofuranosyl pyrimidine nucleosides 1988
9 1-2 p. 114-
1 p.
artikel
144 Synthesis of HOE 602 and analogues. New acyclic nucleoside derivatives with antiviral activity 1988
9 1-2 p. 109-
1 p.
artikel
145 The adenovirus 2 encoded proteinase - A model for development of viral proteinase-specific antiviral agents 1988
9 1-2 p. 91-
1 p.
artikel
146 The antiviral properties of adenosine analogues are correlated with the inhibition of S-adenosylhomocysteine hydrolase 1988
9 1-2 p. 95-
1 p.
artikel
147 The comparative antiviral action of ribavirin against selected bunyaviruses 1988
9 1-2 p. 96-
1 p.
artikel
148 The effect of ribavirin on hepatitis B virus induced suppression of bone marrow progenitor cells in vitro 1988
9 1-2 p. 99-
1 p.
artikel
149 The folate antagonist, methotrexate, is a potent inhibitor of murine and human cytomegalovirus in vitro 1988
9 1-2 p. 108-
1 p.
artikel
150 The followed-up observation of antiviral treatment with small dose interferon in chronic hepatitis B 1988
9 1-2 p. 150-
1 p.
artikel
151 The influence of small dosages of interferon on viruses on different stages of chronic hepatitis B 1988
9 1-2 p. 150-
1 p.
artikel
152 The mechanism of action of antirhinoviral 9-benzylpurines 1988
9 1-2 p. 100-
1 p.
artikel
153 The role of suramin as an antiviral reagent 1988
9 1-2 p. 156-
1 p.
artikel
154 Toxicity evaluation of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride (AVS 206) in Rhesus monkeys: Comparison with ribavirin 1988
9 1-2 p. 136-
1 p.
artikel
155 Treatment of feline leukemia virus induced immunodeficiency syndrome with sustained release implantation of 2,3 dideoxycytidine 1988
9 1-2 p. 86-
1 p.
artikel
156 Treatment of genital HSV2 with r-837 1988
9 1-2 p. 125-
1 p.
artikel
157 Tromantadine inhibits herpes simplex virus induced syncytia 1988
9 1-2 p. 111-
1 p.
artikel
158 Up modulation of the host immune response for anti-viral treatment with DHEA 1988
9 1-2 p. 154-
1 p.
artikel
159 Use of DNA hybridization for antiviral susceptibility testing 1988
9 1-2 p. 115-
1 p.
artikel
                             159 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland